Mississippi SB2117 revises Schedule I of controlled substances to include various opiates, stimulants, depressants, and synthetic cathinones.
Mississippi SB2117 amends Schedule I of controlled substances to include numerous opiates, stimulants, depressants, and synthetic cathinones. These substances, which lack legitimate medical use and have high potency with potential for harm, are now classified under Schedule I. The bill specifies compounds like fentanyl derivatives, synthetic cannabinoids, and various cathinones. Exemptions include certain industrial hemp products and FDA-approved hemp-derived products for human consumption. The act takes effect from July 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.